Analysis of human immunodeficiency virus type 1 drug resistance in children receiving nucleoside analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir (Pediatric AIDS Clinical Trials Group 377)
Susan H. Eshleman, Paul Krogstad, J. Brooks Jackson, You Gan Wang, Sophia Lee, Lee Jen Wei, Shawn Cunningham, Michael Wantman, Andrew Wiznia, George Johnson, Sharon Nachman, Paul Palumbo
Fingerprint
Dive into the research topics of 'Analysis of human immunodeficiency virus type 1 drug resistance in children receiving nucleoside analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir (Pediatric AIDS Clinical Trials Group 377)'. Together they form a unique fingerprint.